Walmart, 3 Pharma Cos. Sued Over Tainted Combo Drug

Law360 (December 3, 2018, 6:27 PM EST) -- Walmart and three pharmaceutical companies were hit with a proposed class action in Florida federal court Saturday alleging they contributed to the production and sale of contaminated batches of a drug used to treat high blood pressure and diabetes.

The batches of irbesartan, a generic version for Sanofi's blockbuster combo drug Avapro, were contaminated with the known carcinogen N-Nitrosodimethylamine, or NDEA, due to manufacturing defects at generics manufacturer Aurobindo Pharma's production facility in India, according to the U.S. Food and Drug Administration. Named plaintiff Barbara Kruk of Illinois says she relied on the packaging labels and the accompanying guarantee that the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS